Anja König

Dr. Anja König is a Managing Director in Basel, Switzerland.She is active in Switzerland and Europe and also responsible for expanding the fund’s presence to Asia Pacific. Prior to joining Novartis she was an Associate Partner at McKinsey and Company, a global consultancy, where she worked with companies in health care in the US, Europe and Emerging Markets. Anja König is a scientist by training and holds a PhD in physics from Cornell University. Anja serves on the boards of Bicycle, Covagen, Heptares, F2G and Nabriva and works with Destiny, Neomics, Oxagen, PharmAbcine, Polyphor and Qurient Therapeutics.

Anja König is the Global Head Novartis Venture Fund at Novartis Venture Fund, based in Switzerland, Europe. With a background in Venture Capital, Anja König has a rich history of leadership and innovation. Anja König studied Ph.D Physics @ Cornell University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.